Scott & Selber, Inc. Zoetis Inc. Transaction History

Scott & Selber, Inc.

$359 Million
Q2 2025

A detailed history of Scott & Selber, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Scott & Selber, Inc. holds 11,652 shares of ZTS stock, worth $1.66 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

11,652

Previous 11,585 0.58%

Holding current value

$1.66 Million

Previous $1.91 Million 4.72%

% of portfolio

0.51%

Previous 0.61%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 17, 2025	BUY	$144.41 - $170.3 $9,675 - $11,410	67 Added 0.58%	11,652 $1.82 Million
Q1 2025 Apr 24, 2025	BUY	$156.48 - $175.67 $782 - $878	5 Added 0.04%	11,585 $1.91 Million
Q4 2024 Feb 06, 2025	SELL	$162.24 - $194.42 $46,887 - $56,187	-289 Reduced 2.43%	11,580 $1.89 Million
Q3 2024 Nov 01, 2024	SELL	$172.58 - $196.48 $9,664 - $11,002	-56 Reduced 0.47%	11,869 $2.32 Million
Q2 2024 Jul 29, 2024	BUY	$145.54 - $178.83 $26,779 - $32,904	184 Added 1.57%	11,925 $2.07 Million
Q1 2024 May 01, 2024	BUY	$165.67 - $199.94 $3,313 - $3,998	20 Added 0.17%	11,741 $1.99 Million
Q4 2023 Feb 01, 2024	SELL	$151.44 - $200.09 $22,261 - $29,413	-147 Reduced 1.24%	11,721 $2.31 Million
Q3 2023 Oct 24, 2023	SELL	$167.14 - $192.77 $4,847 - $5,590	-29 Reduced 0.24%	11,868 $2.07 Million
Q2 2023 Jul 27, 2023	SELL	$160.94 - $186.23 $4,506 - $5,214	-28 Reduced 0.23%	11,897 $2.05 Million
Q1 2023 Apr 18, 2023	BUY	$145.48 - $175.02 $2,473 - $2,975	17 Added 0.14%	11,925 $1.99 Million
Q4 2022 Jan 31, 2023	BUY	$131.14 - $157.47 $393 - $472	3 Added 0.03%	11,908 $1.75 Million
Q3 2022 Oct 21, 2022	BUY	$148.29 - $182.55 $5,783 - $7,119	39 Added 0.33%	11,905 $1.77 Million
Q2 2022 Jul 28, 2022	SELL	$155.97 - $200.09 $20,744 - $26,611	-133 Reduced 1.11%	11,866 $2.04 Million
Q1 2022 May 03, 2022	SELL	$181.39 - $234.03 $29,022 - $37,444	-160 Reduced 1.32%	11,999 $2.26 Million
Q4 2021 Feb 04, 2022	SELL	$193.69 - $247.03 $3,099 - $3,952	-16 Reduced 0.13%	12,159 $2.97 Million
Q3 2021 Nov 05, 2021	SELL	$189.29 - $209.69 $69,658 - $77,165	-368 Reduced 2.93%	12,175 $2.36 Million
Q2 2021 Aug 10, 2021	SELL	$155.9 - $187.99 $9,977 - $12,031	-64 Reduced 0.51%	12,543 $2.34 Million
Q1 2021 May 04, 2021	BUY	$144.0 - $169.39 $7,488 - $8,808	52 Added 0.41%	12,607 $1.99 Million
Q4 2020 Feb 04, 2021	SELL	$157.07 - $174.35 $2.61 Million - $2.9 Million	-16,629 Reduced 56.98%	12,555 $2.08 Million
Q3 2020 Oct 27, 2020	BUY	$137.1 - $165.37 $31,944 - $38,531	233 Added 0.8%	29,184 $4.83 Million
Q2 2020 Aug 04, 2020	SELL	$111.92 - $142.53 $36,374 - $46,322	-325 Reduced 1.11%	28,951 $3.97 Million
Q1 2020 Apr 28, 2020	BUY	$92.66 - $144.94 $17,883 - $27,973	193 Added 0.66%	29,276 $3.45 Million
Q4 2019 Feb 07, 2020	SELL	$116.25 - $133.25 $2.32 Million - $2.66 Million	-19,940 Reduced 40.67%	29,083 $3.85 Million
Q3 2019 Oct 17, 2019	SELL	$112.57 - $128.43 $38,836 - $44,308	-345 Reduced 0.7%	49,023 $6.11 Million
Q2 2019 Aug 01, 2019	BUY	$97.98 - $114.28 $78,971 - $92,109	806 Added 1.66%	49,368 $5.6 Million
Q1 2019 May 03, 2019	SELL	$81.56 - $100.67 $14,680 - $18,120	-180 Reduced 0.37%	48,562 $4.89 Million
Q4 2018 Feb 01, 2019	SELL	$79.28 - $95.27 $62,631 - $75,263	-790 Reduced 1.59%	48,742 $4.17 Million
Q3 2018 Oct 29, 2018	SELL	$83.5 - $93.23 $668 - $745	-8 Reduced 0.02%	49,532 $4.54 Million
Q2 2018 Jul 24, 2018	BUY	$79.9 - $89.2 $18,856 - $21,051	236 Added 0.48%	49,540 $4.22 Million
Q1 2018 May 08, 2018	SELL	$71.51 - $84.69 $32,966 - $39,042	-461 Reduced 0.93%	49,304 $4.12 Million
Q4 2017 Feb 01, 2018	BUY	$63.24 - $72.8 $15,051 - $17,326	238 Added 0.48%	49,765 $3.59 Million
Q3 2017 Nov 06, 2017	SELL	$59.73 - $65.4 $57,460 - $62,914	-962 Reduced 1.91%	49,527 $3.16 Million
Q2 2017 Aug 08, 2017	BUY	N/A	50,489	50,489 $3.15 Million

Others Institutions Holding ZTS

# of Institutions

2,130

Shares Held

431M

Call Options Held

1.47M

Put Options Held

1.45M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $66.6B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scott & Selber, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scott & Selber, Inc. with notifications on news.

Account